Impact of anti-VEGF therapy on distinctive retina layers in patients with macular edema secondary to branch retinal vein occlusion
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Impact of anti-VEGF therapy on distinctive retina layers in patients with macular edema secondary to branch retinal vein occlusion ; volume:23 ; number:1 ; day:25 ; month:5 ; year:2023 ; pages:1-9 ; date:12.2023
BMC ophthalmology ; 23, Heft 1 (25.5.2023), 1-9, 12.2023
- Urheber
-
Wang, Hui
Wang, Chanjuan
Zhang, Shaochi
Liu, Jun
Bi, Xiaojun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-023-02981-7
- URN
-
urn:nbn:de:101:1-2023091013132357264124
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Hui
- Wang, Chanjuan
- Zhang, Shaochi
- Liu, Jun
- Bi, Xiaojun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Anti-VEGF : 13 tables
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Book Review: Anti-VEGF Use in Ophthalmology
Future of anti-VEGF: biosimilars and biobetters
Development and validation of CNN-MLP models for predicting anti-VEGF therapy outcomes in diabetic macular edema
Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema
Effect of intraocular anti-VEGF on cystoid macular edema associated with Henoch-Schonlein purpura-a case report
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Anti-VEGF : 13 tables
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Book Review: Anti-VEGF Use in Ophthalmology
Future of anti-VEGF: biosimilars and biobetters
Development and validation of CNN-MLP models for predicting anti-VEGF therapy outcomes in diabetic macular edema
Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema
Effect of intraocular anti-VEGF on cystoid macular edema associated with Henoch-Schonlein purpura-a case report
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Anti-VEGF : 13 tables
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Book Review: Anti-VEGF Use in Ophthalmology
Future of anti-VEGF: biosimilars and biobetters
Development and validation of CNN-MLP models for predicting anti-VEGF therapy outcomes in diabetic macular edema
Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema